fbpx
DCB Open Innovation Challenge 2024: Meet our Top 6!

DCB Open Innovation Challenge 2024: Meet our Top 6!

DCB Open Innovation Challenge 2024: Meet our Top 6!

The DCB Innovation Challenge 2024 is entering its final round! Explore the six innovations which have been chosen to move on to the bootcamp and finale, after rigorous evaluation by our esteemed jury.

Jorge Bondia (ES): AMIC Health – A digital ecosystem to educate children with type 1 diabetes through safe experimentation with gamified diabetes simulators

“AMIC Health is a digital ecosystem for the healthcare professional to educate children with type 1 diabetes through safe experimentation with gamified diabetes simulators and quantify effectiveness.”

Christine Brännvall (SE) : Beep Insights – Calculating insulin resistance based on level of physical activity

“The Beep app feature uses lactate measurement to estimate insulin resistance in relation to physical activity, CGM data, food  intake and sleep. Beep has built the world’s first in-app lactate step testing feature where both the test and the results are easily managed with a lactate testing device and analysed for you, without the need of any administration.”

Frédérik Plourde (CH) : Neuria – Evidence-based Neurocognitive Digital Therapeutics to restore healthy consumption behaviors without awareness

“Neuria’s gamified solution offers an evidence-based neurocognitive digital therapeutic that restores healthy consumption behaviors without awareness. Tested in 500+ individuals, it leverages brain plasticity and reduces cravings by 20%, consumption by 25%, and weight by 2-3% after a 15-hour intervention.”

Sufyan Hussain (UK) : Innodose – Device to reduce incidence of lipohypertrophy in long-term insulin users

“INNODOSE gamifies the injection process to reduce the incidence of lipohypertrophy in insulin-treated diabetes – with a co-design informed innovation of a novel insulin pen and pen-adaptor, drawing on collaboration between academics, clinicians, practitioners, engineers and designers at King’s College London, and with a focus on co-production with the end users.”

Muhammad Mujeeb-U-Rahman (US): CGM+ – Unleashing the Power of Next-Gen Monitoring for Diabetes

“Integrated Medical Sensors (IMS) has developed the world’s smallest, first fully-integrated (single chip) and first multi-sensor minimally invasive CGM, taking diabetes monitoring to the next level. It can monitor glucose using multiple independent sensors on the same device. In addition, it measures physiological parameters (e.g., tissue temperature) using the same device. Moreover, it can also measure multiple analytes (e.g., glucose and ketones) using a single device.”

Yuta Matsuda (US) : Genomelink – Innovative DNA Testing: A New Horizon in Type 1 Diabetes Diagnosis

“Misdiagnosis between T1D and T2D is common due to a lack of accessible diagnostic methods. Our new DNA test offers a more accessible and accurate tool for diagnosis. Unlike the fluctuating antibody levels, genetic markers associated with T1D do not change over a person’s lifespan, providing a stable diagnostic criterion.”

We are looking forward to entering this next round of our Innovation Challenge: a one week bootcamp in the Swiss mountains and the grand finale on 3 October!

    Download the PDF Overview

    Sign up for our newsletter and stay up to date.

    * Pflichtfelder
    DSGVO *

    DCB Research AG

    Freiburgstrasse 3
    3010 Bern
    Switzerland

    DCB Open Innovation Challenge 2024: Meet our Top 20!

    DCB Open Innovation Challenge 2024: Meet our Top 20!

    DCB Open Innovation Challenge 2024: Meet our Top 20!

    The DCB Open Innovation Challenge 2024 is entering its next round! From all 100 submitted ideas, our evaluation committee has now selected the Top 20.

    Meet our Top 20!

    Following a meticulous evaluation of incredible 100 submissions for our Open Innovation Challenge, our team has selected the top 20 ideas to advance to the next phase.

    We are pleased to announce the innovative concepts that have successfully progressed. This year’s submissions have surpassed expectations, and we eagerly anticipate mentoring with these 20 outstanding innovators. Among them, 2 from the US and 4 from around the globe will later be chosen as finalists, earning the opportunity to participate in our bootcamp and competing for the win at our prestigious award ceremony.

    As we embark on this journey, we invite you to explore the detailed profiles of the top 20 innovators in the attached PDF. Let us collectively celebrate innovation and collaboration as we move forward!

    Downloads

    More recent news

    Sign up for our newsletter and stay up to date.

    * Pflichtfelder
    DSGVO *

    DCB Research AG

    Freiburgstrasse 3
    3010 Bern
    Switzerland

    The DCB Open Innovation Challenge is Back: Submit Your Idea Now!

    The DCB Open Innovation Challenge is Back: Submit Your Idea Now!

    The DCB Open Innovation Challenge is Back: Submit Your Idea Now!

    For the fourth time, the Diabetes Center Berne is launching the Open Innovation Challenge with the aim of specifically promoting innovative projects in the field of diabetes management on Swiss and international level. Participating innovtors benefit from professional expert feedback, and the six best projects receive access to a bootcamp. The finalists will receive prize money of up to USD 100,000 and further support from the DCB. The DCB Innovation Challenge is the world’s largest diabetes technology award with international appeal.

    Can Your Idea Change Diabetes Management?

    More than 537 million people worldwide live with diabetes, which means a constant challenge in everyday life for those affected. Technological innovations make an important contribution to making it easier to deal with diabetes – whether it is measuring glucose levels, planning the amount of insulin needed via an app or even using automated insulin delivery systems. But despite these enormous advances in diabetes technology, there is still a great, unmet need for innovative technical solutions. These should help to ease the challenge for users in everyday life and improve the lives of people with diabetes in the long term.

    The DCB Open Innovation Challenge was initiated in 2021 with the aim of closing these gaps in diabetes technology with translational research. The goal of the challenge is to identify unique solutions which can make life easier for people with diabetes. Whether you’re a researcher, healthcare professional, start-up founder, or someone living with diabetes, your ideas are invaluable to us. We’re seeking diverse perspectives and innovative solutions to enhance the quality of life for individuals with diabetes.

     

    What’s in it for you?

    After a first round and feedback from the expert jury, the top 20 will enter a mentoring program. Two US-based innovators and four innovators from the rest of the world will be invited to an individually tailored bootcamp in the picturesque Swiss alps and will then pitch their final ideas at the grand DCB Start-Up Night in Berne, Switzerland, on 3 October 2024. Additionally, all finalists have the opportunity to present their ideas at the Diabetes Technology Meeting in the US on 15–17 October 2024.​

    The winning project will be selected by an international expert jury and rewarded with USD 100,000 in funding and in-kind support – making the DCB Open Innovation Challenge the world’s largest diabetes technology award with international appeal. You will get access to a global network of experts from the field – all while your idea remains entirely yours.

    Don’t miss out on this unparalleled opportunity to turn your idea into reality. Submit your idea by April 30 at our innovation platform innovation.dcberne.com

    More recent news

    Sign up for our newsletter and stay up to date.

    * Pflichtfelder
    DSGVO *

    DCB Research AG

    Freiburgstrasse 3
    3010 Bern
    Switzerland

    Diabetes Center Berne and Diabetes Technology Society Collaborate for the 2024 DCB Open Innovation Challenge

    Diabetes Center Berne and Diabetes Technology Society Collaborate for the 2024 DCB Open Innovation Challenge

    Diabetes Center Berne and Diabetes Technology Society Collaborate for the 2024 DCB Open Innovation Challenge

    We are very excited to announce the launch of the 2024 DCB Open Innovation Challenge for 1 April 2024, this year in collaboration with the Diabetes Technology Society!

    Can Your Idea Change Diabetes Management Forever?

    We are excited to announce the collaboration of the Diabetes Center Berne and the Diabetes Technology Society for the 2024 DCB Open Innovation Challenge, launching on 1 April 2024.​

    The DCB Open Innovation Challenge was initiated in 2021 and is the largest innovation challenge in the field of diabetes technology. The goal of the challenge is to identify unique solutions which can make life easier for people with diabetes. Anyone with an idea can apply – whether researcher, healthcare professional, start-up or person living with diabetes. We want to hear from you!​

    In 2024, two US-based innovators and four innovators from the rest of the world will be selected to pitch their final ideas at the grand DCB Start-Up Night in Berne, Switzerland, on 3 October 2024. Additionally, all finalists have the opportunity to present their ideas at the Diabetes Technology Meeting in the US on 15–17 October 2024.​ ​

    Save the dates and seize the opportunity to watch your idea become reality: www.dcberne.com/en/innovation-challenge

    More recent news

    Sign up for our newsletter and stay up to date.

    * Pflichtfelder
    DSGVO *

    DCB Research AG

    Freiburgstrasse 3
    3010 Bern
    Switzerland

    Meet us at ATTD!

    Meet us at ATTD!

    Meet us at ATTD!

    The ATTD congress in Florence, Italy, is just around the corner and different members of the DCB team will be on-site. Meet us there to discuss our services, potential collaborations or just chat over a coffee!

    DCB at ATTD 2024

    ATTD (Advanced Technologies & Treatments in Diabetes) is the leading international meeting point for all those involved and interested in diabetes technology. DCB is thrilled to participate in this prestigious event in Florence, Italy, fostering connections with like-minded enthusiasts dedicated to diabetes technology, innovation, and research.

    We will be present with different members of our team from different divisions. Additionally, members of our Lived Experience Panel will also be attending. We are looking forward to attending insightful Scientific sessions, exploring new innovative solutions and above all: networking with you!

    If you are attending ATTD and are eager to learn more about our services, the Open Innovation Challenge, our community, or any other topics – please reach out to those attending and book a coffee slot. We look forward to connecting with you!

     

    Unable to attend ATTD but curious about our services and activities? We would also be happy to schedule calls for after the conference to discuss potential collaborations. Feel free to reach out to individual members of our team.

    More recent news

    Sign up for our newsletter and stay up to date.

    * Pflichtfelder
    DSGVO *

    DCB Research AG

    Freiburgstrasse 3
    3010 Bern
    Switzerland

    DCB Innovation Challenge winner Una Health approved as Digital Health Application in Germany (DiGa)

    DCB Innovation Challenge winner Una Health approved as Digital Health Application in Germany (DiGa)

    DCB Innovation Challenge winner Una Health approved as Digital Health Application in Germany (DiGa)

    Berlin, February 13, 2024 – The Una Health smartphone app for diabetes, a digital application for the treatment of type 2 diabetes, has been included in the DiGA directory by the Federal Institute for Drugs and Medical Devices (BfArM) in Germany as a digital health application (DiGA) and can now be prescribed on prescription. Una Health for Diabetes is the first German DiGA with a holistic and personalized treatment approach that combines blood glucose monitoring, lifestyle, drug treatment and mental health.

    Una Health approved as German Digital Health Application (DiGA) for diabetes: New guideline-based solution for type 2 diabetes

    In 2022, Una Health won the DCB Open Innovation Challenge in the Digital Diabetes category. Now, they have achieved a major milestone: the app for managing type 2 diabetes has now been qualified as a DiGA (German Digital Health Application) and can now be prescribed on prescription in Germany.

    Type 2 diabetes affects almost 9 million people in Germany, and the trend is rising. The disease requires continuous monitoring and blood glucose control in order to avoid concomitant diseases such as renal insufficiency or retinal damage and a negative course of the disease. The approval of Una Health for diabetes has now made it possible to offer a non-drug therapy option to improve the quality of life for people living with type 2 diabetes. The application combines continuous glucose meter and dietary data in a mobile app that helps people with type 2 diabetes understand the reasons for their blood glucose fluctuations and make long-term lifestyle changes to keep their glucose levels stable. The therapy is available for all people with a diabetestype 2 diagnosis from the age of 18 (ICD 10 E11.-).

    Function and evidence

    By analysing individual blood glucose reactions, the app offers personalised lifestyle recommendations that improve blood glucose control. With evidence-based content, goal functions and coaching messages, the app facilitates effective implementation of lifestyle changes. This innovative approach enables users to expand their knowledge about diabetes and optimise their lifestyle in a personalized way. In a clinical study in collaboration with Prof. Dr. med. Peter Schwarz, diabetologist at the TU Dresden and President of the International Diabetes Federation (IDF), it was shown that the use of Una Health for Diabetes led to a significant improvement in blood glucose levels, weight and quality of life in people with type 2 diabetes. 96% of users would recommend the application to others.

    Development

    “We are thrilled to introduce Una Health for Diabetes to the public after an intensive development phase. Our non-drug treatment approach is helping to improve the care and quality of life for people with type 2 diabetes,” says Matthew Fenech, MD, diabetologist and founder of Una Health. “Our mission is to combine innovative technology with medical expertise to create solutions for the millions of people with diabetes and caregivers that are both easily accessible and easy to integrate into everyday life. We want to empower people to take a proactive approach to their health and better understand the impact of lifestyle and behavior.”

    Una Health for Diabetes was developed with leading diabetologists and nutritionists to high clinical and data protection standards in Germany. Professor Martin Möckel, MD, internist and Medical Director of Emergency and Acute Medicine at Charité Berlin and Chairman of the “Digital Health Applications/AI in Guidelines” working group at the German Society of Internal Medicine (DGIM), confirms: “Una Health GmbH has developed a program that has a lasting impact on patients’ lifestyles and motivates them to change their behaviour by directly reflecting back to them”. Una Health for Diabetes 2023 impressed the expert jury of the DiGA Pitch Battle at the DGIM congress in Wiesbaden with its sustainable concept.

     

    The application is now available for Android and iOS devices. To find out more about use and prescription, visit the website at https://unahealth.de/for-partners.

     

    About Una Health:

    The start-up Una Health won the DCB Open Innovation Challenge in the Digital Diabetes category in 2022. Una Health, based in Germany, is a leading provider of digital health applications with a mission to address the ever-growing burden of metabolic disease. By providing personalised tools and resources, Una Health helps users to manage their blood glucose levels, adapt their lifestyle and develop healthier habits in the long term. The mission is to combine innovative technology with medical expertise to provide personalised solutions that enable people to proactively address their health and lead a fulfilling life.

    Links

    Contact

    Press department Una Health

    E-Mail: presse@unahealth.de

    Phone: +49 – 30 – 863 232 552

    Sign up for our newsletter and stay up to date.

    * Pflichtfelder
    DSGVO *

    DCB Research AG

    Freiburgstrasse 3
    3010 Bern
    Switzerland